Diseases such as atherosclerosis that require the use of clopidogrel
Conditions
Interventions
A group of Tibetan patients taking clopidogrel for 30 days or more:None
Sponsors
Hospital of Chengdu Office of People’s Government of Tibetan Autonomous Region (Hospital.C.T.)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Tibetan patients who have taken clopidogrel for 30 days or more as prescribed by a specialist physician; 2.Age =18 years; 3.Patients voluntarily participate in this study and have signed an informed consent form in writing;
Exclusion criteria
Exclusion criteria: 1.Patients with contraindications to antiplatelet therapy; 2.Individuals with multiple organ dysfunction syndrome (MODS); 3.Autoimmune diseases; 4.The patient refuses to participate in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary composite endpoint (death,myocardial infarction,confirmed stent thrombosis,stroke,etc.);Bleeding event;Platelet inhibition rate; | — |
Countries
China
Contacts
Public ContactXiaosi Li
Hospital of Chengdu Office of People’s Government of Tibetan Autonomous Region (Hospital.C.T.)
Outcome results
None listed